• Profile
Close

Ultrasound echogenicity reveals the response of breast cancer to chemotherapy

Clinical Imaging Jan 31, 2019

Dobruch-Sobczak K, et al. - In this prospective ultrasound (US) analysis, researchers assessed the US response in patients with breast cancer (BC) while undergoing neoadjuvant chemotherapy (NAC). This investigation was performed on 19 malignant tumors before NAC treatment and 7 days following each first four courses of NAC in 13 patients. A statistically significant relationship was found between breast tumors' echogenicity in US, neoplasm size, and stiffness and NAC response. The change in tumor echogenicity could especially foresee a pathological response with reasonable accuracy and can be considered in NAC monitoring. Important factors in predicting response to NAC were lesion size and elasticity.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay